MicroPort CardioFlow Agrees to Consolidation Offer From Controlling Shareholder

MT Newswires Live

Sep 30

MicroPort CardioFlow Medtech (HKG:2160) agreed to merge with MicroPort Cardiac Rhythm Management in a deal valued at $680 million, according to a Hong Kong bourse filing Monday.

Shares of the medical company gained over 3% in morning trade Tuesday.

Under the proposal, MicroPort Scientific's (HKG:0853) CRM business under its 50.13%-owned MicroPort Cardiac Rhythm Management subsidiary will be combined with MicroPort CardioFlow, which oversees the group's structural heart disease business.

MicroPort CardioFlow said it would acquire the business via the issue of 3,953,847,407 shares of the company priced at HK$1.35 apiece.

The shares represent 164% of the company's issued share capital and 62% on an enlarged basis.

MicroPort Scientific is a controlling shareholder of MicroPort CardioFlow and owns 46.12% of the business.

Its shares were up 6% in morning trade Tuesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2571201391"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2571201391\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2571201391?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-30 11:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2571201391","market":"sg","top_or_hot":-1,"title":"MicroPort CardioFlow Agrees to Consolidation Offer From Controlling Shareholder","media":"MT Newswires Live","content":"<html><body><p> MicroPort CardioFlow Medtech (HKG:2160) agreed to merge with MicroPort Cardiac Rhythm Management in a deal valued at $680 million, according to a Hong Kong bourse filing Monday.</p><p>Shares of the medical company gained over 3% in morning trade Tuesday.</p><p>Under the proposal, MicroPort Scientific's (HKG:0853) CRM business under its 50.13%-owned MicroPort Cardiac Rhythm Management subsidiary will be combined with MicroPort CardioFlow, which oversees the group's structural heart disease business.</p><p>MicroPort CardioFlow said it would acquire the business via the issue of 3,953,847,407 shares of the company priced at HK$1.35 apiece.</p><p>The shares represent 164% of the company's issued share capital and 62% on an enlarged basis.</p><p>MicroPort Scientific is a controlling shareholder of MicroPort CardioFlow and owns 46.12% of the business.</p><p>Its shares were up 6% in morning trade Tuesday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MicroPort CardioFlow Agrees to Consolidation Offer From Controlling Shareholder</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroPort CardioFlow Agrees to Consolidation Offer From Controlling Shareholder\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-30 11:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> MicroPort CardioFlow Medtech (HKG:2160) agreed to merge with MicroPort Cardiac Rhythm Management in a deal valued at $680 million, according to a Hong Kong bourse filing Monday.</p><p>Shares of the medical company gained over 3% in morning trade Tuesday.</p><p>Under the proposal, MicroPort Scientific's (HKG:0853) CRM business under its 50.13%-owned MicroPort Cardiac Rhythm Management subsidiary will be combined with MicroPort CardioFlow, which oversees the group's structural heart disease business.</p><p>MicroPort CardioFlow said it would acquire the business via the issue of 3,953,847,407 shares of the company priced at HK$1.35 apiece.</p><p>The shares represent 164% of the company's issued share capital and 62% on an enlarged basis.</p><p>MicroPort Scientific is a controlling shareholder of MicroPort CardioFlow and owns 46.12% of the business.</p><p>Its shares were up 6% in morning trade Tuesday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物医药B类股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2571201391","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2571201391","pubTimestamp":1759203671,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"MicroPort CardioFlow Medtech  agreed to merge with MicroPort Cardiac Rhythm Management in a deal valued at $680 million, according to a Hong Kong bourse filing Monday.Shares of the medical company gained over 3% in morning trade Tuesday.Under the proposal, MicroPort Scientific's  CRM business under its 50.13%-owned MicroPort Cardiac Rhythm Management subsidiary will be combined with MicroPort CardioFlow, which oversees the group's structural heart disease business.MicroPort CardioFlow said it would acquire the business via the issue of 3,953,847,407 shares of the company priced at HK$1.35 apiece.The shares represent 164% of the company's issued share capital and 62% on an enlarged basis.MicroPort Scientific is a controlling shareholder of MicroPort CardioFlow and owns 46.12% of the business.Its shares were up 6% in morning trade Tuesday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1574":"生物医药B类股","00853":"微创医疗","BK1585":"昨日强势股","BK1583":"高瓴概念","BK1100":"医疗保健设备","BK1589":"北水核心资产","02160":"心通医疗-B"},"translate_title":"微创心通同意控股股东的合并要约","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00853":0.9,"02160":1},"content_text":"MicroPort CardioFlow Medtech (HKG:2160) agreed to merge with MicroPort Cardiac Rhythm Management in a deal valued at $680 million, according to a Hong Kong bourse filing Monday.Shares of the medical company gained over 3% in morning trade Tuesday.Under the proposal, MicroPort Scientific's (HKG:0853) CRM business under its 50.13%-owned MicroPort Cardiac Rhythm Management subsidiary will be combined with MicroPort CardioFlow, which oversees the group's structural heart disease business.MicroPort CardioFlow said it would acquire the business via the issue of 3,953,847,407 shares of the company priced at HK$1.35 apiece.The shares represent 164% of the company's issued share capital and 62% on an enlarged basis.MicroPort Scientific is a controlling shareholder of MicroPort CardioFlow and owns 46.12% of the business.Its shares were up 6% in morning trade Tuesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}